Concluded

FDA's Mifepristone Safety Review Controversy

3 articles from 3 outlets First seen: June 05, 2026

1 left · 1 center · 1 unclassified · Earliest publisher-stamped report: The Hill and Scientific American

See how each outlet covered this ↓ Compare the framing and bias scores below. A written neutral summary is still pending — every Pure Report account must clear two verification gates first — but the full coverage record is here now.

Framing spectrum · 3 outlets

Scientific American · 36/100 · Mainstream The Hill · 42/100 · Mainstream Washington Examiner · 45/100 · Mainstream

wirepublicmainstream flavoredpartisanadvocacy

Range 36–45 (Mainstream → Mainstream) Average 41/100 Lean: 1 left · 0 right · 2 neutral

Coverage patterns

Earliest report in our feed set (publisher timestamps): among the earliest were The Hill and Scientific American — stamps within 90 minutes.

Lean	Outlets	Articles	Who
Left	1	1	Washington Examiner
Center	1	1	The Hill
Unclassified	1	1	Scientific American

Report-by-report timeline · 3

Jun 05 13:59 The Hill FDA conducting safety review of mifepristone Jun 05 14:50 Scientific American FDA Launches Study on Mifepristone Jun 05 15:55 Washington Examiner FDA Initiates Safety Review of Mifepristone Amid Regulatory Pressure

Coverage patterns reflect only the ~50 feeds Pure Report ingests — not the full media universe. Timestamps are publisher-reported. Lean labels are Pure Report's classification. Articles are grouped by automated clustering, and counts include syndicated wire copies.

Compare the coverage

Scientific American 36 Mainstream FDA Launches Study on Mifepristone The Hill 42 Mainstream FDA conducting safety review of mifepristone Washington Examiner
LEANS LEFT 45 Mainstream FDA Initiates Safety Review of Mifepristone Amid Regulatory Pressure